---
title: "JIAODA ONLLY: Received the notice of case filing from the Securities Regulatory Commission"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248150694.md"
description: "JIAODA ONLLY announced that the company received the \"Notice of Case Filing\" from the China Securities Regulatory Commission on July 11, 2025. Due to the company's suspected violations of information disclosure laws and regulations, the China Securities Regulatory Commission has decided to file a case against the company. The company will actively cooperate with the relevant work and fulfill its information disclosure obligations"
datetime: "2025-07-11T11:02:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248150694.md)
  - [en](https://longbridge.com/en/news/248150694.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248150694.md)
---

# JIAODA ONLLY: Received the notice of case filing from the Securities Regulatory Commission

JIAODA ONLLY announced that on July 11, 2025, it received the "Notice of Case Filing" from the China Securities Regulatory Commission (CSRC). Due to the company's suspected violations of information disclosure laws and regulations, the CSRC has decided to file a case against the company. The company will actively cooperate with the relevant work and fulfill its information disclosure obligations

### Related Stocks

- [600530.CN](https://longbridge.com/en/quote/600530.CN.md)

## Related News & Research

- [Shanghai Henlius says China regulator clears HLX48 Phase 1 trial IND for solid tumors](https://longbridge.com/en/news/287189347.md)
- [Sparebanken Øst Boosts Employee Savings Scheme With Equity Certificate Buyback](https://longbridge.com/en/news/287108450.md)
- [Orion Pharma to reveal initial results from Phase 1/2 TEADES study of ODM-212 at 2026 ASCO® Meeting.](https://longbridge.com/en/news/287177935.md)
- [08:57 ETCrunchCup Secures U.S. Utility Patent](https://longbridge.com/en/news/286917029.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)